At LogiPharma USA 2026, Mark Talens explains where pharma gains the most from shared distribution visibility.
News|Articles|October 12, 2026
How Precision and Share of Answer Will Reshape Pharma Marketing
Author(s)Hemal Somaiya
As HCPs turn to AI tools for clinical answers, pharma brands must optimize for share of answer over share of voice and speed up data operations.
Advertisement
Advertisement
Pharmaceutical marketing is undergoing a long-overdue shift. Outdated ‘spray-and-pray’ tactics are giving way to hyper-personalized engagement that gives healthcare professionals (HCPs) and patients exactly what they need, when they need it. At the same time, as
Related to this article
At LogiPharma USA 2026, quality leaders explained why connected data, risk-based prioritization, and human accountability must come before AI in supply chain compliance.
In this Q&A, Doceree CEO Harshit Jain, MD, explains why AI should inform prescribing decisions, not drive them, and how sales reps own relationships while AI extends reach.
Swisslog's Mark Beers discusses how software helps pharma supply chains adapt to shifting portfolios, strengthen inventory verification and build trust.
At LogiPharma USA 2026, leaders from J&J, Sun Pharma, Accord Healthcare, and Freehand discussed visibility, redundancy tradeoffs, and AI's role in resilient pharma supply chains.
McKesson's Chris Van Norman previews his LogiPharma USA keynote on demand signal sharing, AI, and precision distribution for targeted therapies.
LogiPharma's Charleen Ring and McKesson's Chris Van Norman preview the 2026 agenda, sessions to prioritize and a day two fireside chat.
Patient support data that is trusted, connected and delivered into field workflows can move access teams from reporting to faster patient intervention.
Advertisement
Advertisement